본문 바로가기
KERD
논문KCI 등재

Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer

Laura M. Stinton|Eldon A. Shaffer
거트앤리버 소화기연관학회협의회|2012.04|Gut and Liver|제6권 제2호|pp. 172-187|DOI http://dx.doi.org/

1

조회

0

다운로드

18

인용

0

참고문헌

키워드

Gallbladder cancerCholecystectomyGallstonesGallbladder polyps

초록

Diseases of the gallbladder are common and costly. The best epidemiological screening method to accurately determine point prevalence of gallstone disease is ultrasonography. Many risk factors for cholesterol gallstone formation are not modifiable such as ethnic background, increasing age,female gender and family history or genetics. Conversely, the modifi able risks for cholesterol gallstones are obesity, rapid weight loss and a sedentary lifestyle. The rising epidemic of obesity and the metabolic syndrome predicts an escalation of cholesterol gallstone frequency. Risk factors for biliary sludge include pregnancy, drugs like ceftiaxone, octreotide and thiazide diuretics, and total parenteral nutrition or fasting. Diseases like cirrhosis, chronic hemolysis and ileal Crohn’s disease are risk factors for black pigment stones. Gallstone disease in childhood, once considered rare, has become increasingly recognized with similar risk factors as those in adults, particularly obesity. Gallbladder cancer is uncommon in developed countries. In the U.S., it accounts for only ~ 5,000cases per year. Elsewhere, high incidence rates occur in North and South American Indians. Other than ethnicity and female gender, additional risk factors for gallbladder cancer include cholelithiasis, advancing age, chronic infl ammatory conditions affecting the gallbladder, congenital biliary abnormalities,and diagnostic confusion over gallbladder polyps.

Abstract

Diseases of the gallbladder are common and costly. The best epidemiological screening method to accurately determine point prevalence of gallstone disease is ultrasonography. Many risk factors for cholesterol gallstone formation are not modifiable such as ethnic background, increasing age,female gender and family history or genetics. Conversely, the modifi able risks for cholesterol gallstones are obesity, rapid weight loss and a sedentary lifestyle. The rising epidemic of obesity and the metabolic syndrome predicts an escalation of cholesterol gallstone frequency. Risk factors for biliary sludge include pregnancy, drugs like ceftiaxone, octreotide and thiazide diuretics, and total parenteral nutrition or fasting. Diseases like cirrhosis, chronic hemolysis and ileal Crohn’s disease are risk factors for black pigment stones. Gallstone disease in childhood, once considered rare, has become increasingly recognized with similar risk factors as those in adults, particularly obesity. Gallbladder cancer is uncommon in developed countries. In the U.S., it accounts for only ~ 5,000cases per year. Elsewhere, high incidence rates occur in North and South American Indians. Other than ethnicity and female gender, additional risk factors for gallbladder cancer include cholelithiasis, advancing age, chronic infl ammatory conditions affecting the gallbladder, congenital biliary abnormalities,and diagnostic confusion over gallbladder polyps.

참고문헌 (226)

  1. Gracie WA, "The natural history of silent gallstones: the innocent gallstone is not a myth", N Engl J Med, 307, pp.798~800 (1982)
  2. Shaffer EA, "Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?", Curr Gastroenterol Rep, 7, pp.132~140 (2005)
  3. Kratzer W, "Prevalence of gallstones in sonographic surveys worldwide", J Clin Ultrasound, 27, pp.1~7 (1999)
  4. Pedersen G, "Influence of laparoscopic cholecystectomy on the prevalence of operations for gallstones in Norway", Eur J Surg, 168, pp.464~469 (2002)
  5. Schirmer BD, "Cholelithiasis and cholecystitis", J Long Term Eff Med Implants, 15, pp.329~338 (2005)
  6. Everhart JE, "Prevalence and ethnic differences in gallbladder disease in the United States", Gastroenterology, 117, pp.632~639 (1999)
  7. Tazuma S, "Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic)", Best Pract Res Clin Gastroenterol, 20, pp.1075~1083 (2006)
  8. Sandler RS, "The burden of selected digestive diseases in the United States", Gastroenterology, 122, pp.1500~1511 (2002)
  9. Everhart JE, "Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases", Gastroenterology, 136, pp.376~386 (2009)
  10. Shaheen NJ, "The burden of gastrointestinal and liver diseases, 2006", Am J Gastroenterol, 101, pp.2128~2138 (2006)
  11. Ruhl CE, "Gallstone disease is associated with increased mortality in the United States", Gastroenterology, 140, pp.508~516 (2011)
  12. Grimaldi CH, "Increased mortality with gallstone disease: results of a 20-year population-based survey in Pima Indians", Ann Intern Med, 118, pp.185~190 (1993)
  13. Lindkvist B, "Trends in incidence of acute pancreatitis in a Swedish population: is there really an increase?", Clin Gastroenterol Hepatol, 2, pp.831~837 (2004)
  14. Legorreta AP, "Increased cholecystectomy rate after the introduction of laparoscopic cholecystectomy", JAMA, 270, pp.1429~1432 (1993)
  15. Marshall D, "The impact of laparoscopic cholecystectomy in Canada and Australia", Health Policy, 26, pp.221~230 (1994)
  16. Kang JY, "Gallstones: an increasing problem: a study of hospital admissions in England between 1989", 1990 and 1999, Aliment Pharmacol Ther, pp.2003 (2000), 17[DOI]
  17. Nenner RP, "Increased cholecystectomy rates among Medicare patients after the introduction of laparoscopic cholecystectomy", J Community Health, 19, pp.409~415 (1994)
  18. Russo MW, "Digestive and liver diseases statistics, 2004", Gastroenterology, 126, pp.1448~1453 (2004)
  19. Zacks SL, "A populationbased cohort study comparing laparoscopic cholecystectomy and open cholecystectomy", Am J Gastroenterol, 97, pp.334~340 (2002)
  20. Gibney EJ, "Asymptomatic gallstones", Br J Surg, 77, pp.368~372 (1990)
  21. Sakorafas GH, "Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy", Dig Dis Sci, 52, pp.1313~1325 (2007)
  22. Halldestam I, "Development of symptoms and complications in individuals with asymptomatic gallstones", Br J Surg, 91, pp.734~738 (2004)
  23. Thistle JL, "The natural history of cholelithiasis: the National Cooperative Gallstone Study", Ann Intern Med, 101, pp.171~175 (1984)
  24. Ransohoff DF, "Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival", Ann Intern Med, 99, pp.199~204 (1983)
  25. Friedman GD, "Natural history of asymptomatic and symptomatic gallstones", Am J Surg, 165, pp.399~404 (1993)
  26. Schirmer BD, "Cholelithiasis and cholecystitis", J Long Term Eff Med Implants, 15, pp.329~338 (2005)
  27. Kapoor VK, "Cholecystectomy in patients with asymptomatic gallstones to prevent gall bladder cancer: the case against", Indian J Gastroenterol, 25, pp.152~154 (2006)
  28. Bonatsos G, "Laparoscopic cholecystectomy in adults with sickle cell disease", Surg Endosc, 15, pp.816~819 (2001)
  29. Ebert EC, "Gastrointestinal and hepatic complications of sickle cell disease", Clin Gastroenterol Hepatol, 8, pp.483~489 (2010)
  30. Kao LS, "Should cholecystectomy be performed for asymptomatic cholelithiasis in transplant patients?", J Am Coll Surg, 197, pp.302~312 (2003)
  31. Shiffman ML, "Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity", Am J Gastroenterol, 86, pp.1000~1005 (1991)
  32. Jørgensen T, "Abdominal symptoms and gallstone disease: an epidemiological investigation", Hepatology, 9, pp.856~860 (1989)
  33. Traverso LW, "Clinical manifestations and impact of gallstone disease", Am J Surg, 165, pp.405~409 (1993)
  34. Fenster LF, "What symptoms does cholecystectomy cure? Insights from an outcomes measurement project and review of the literature", Am J Surg, 169, pp.533~538 (1995)
  35. Festi D, "Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL)", Hepatology, 30, pp.839~846 (1999)
  36. Berhane T, "Pain attacks in non-complicated and complicated gallstone disease have a characteristic pattern and are accompanied by dyspepsia in most patients: the results of a prospective study", Scand J Gastroenterol, 41, pp.93~101 (2006)
  37. Weinert CR, "Relationship between persistence of abdominal symptoms and successful outcome after cholecystectomy", Arch Intern Med, 160, pp.989~995 (2000)
  38. Vetrhus M, "Pain persists in many patients five years after removal of the gallbladder: observations from two randomized controlled trials of symptomatic, noncomplicated gallstone disease and acute cholecystitis", J Gastrointest Surg, 9, pp.826~831 (2005)
  39. Mertens MC, "Risk assessment in cholelithiasis: is cholecystectomy always to be preferred?", J Gastrointest Surg, 14, pp.1271~1279 (2010)
  40. Thistle JL, "Factors that predict relief from upper abdominal pain after cholecystectomy", Clin Gastroenterol Hepatol, 9, pp.891~896 (2011)
  41. Shaffer E, "Acalculous biliary pain: new concepts for an old entity", Dig Liver Dis, 35(Suppl 3), pp.S20~S25 (2003)
  42. DiBaise JK, "Cholecystokinincholescintigraphy in adults: consensus recommendations of an interdisciplinary panel", Clin Gastroenterol Hepatol, 9, pp.376~384 (2011)
  43. Gurusamy KS, "Cholecystectomy for suspected gallbladder dyskinesia", Cochrane Database Syst Rev, (1), pp.CD007086~ (2009)
  44. Shaffer EA, "Gallstone disease: epidemiology of gallbladder stone disease", Best Pract Res Clin Gastroenterol, 20, pp.981~996 (2006)
  45. Everhart JE, "Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study", Hepatology, 35, pp.1507~1512 (2002)
  46. Miquel JF, "Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris", Gastroenterology, 115, pp.937~946 (1998)
  47. Everhart JE, "Gallstones and ethnicity in the Americas", J Assoc Acad Minor Phys, 12, pp.137~143 (2001)
  48. Diehl AK, "Special health problems of Mexican-Americans: obesity, gallbladder disease, diabetes mellitus, and cardiovascular disease", Adv Intern Med, 34, pp.73~96 (1989)
  49. Maurer KR, "Prevalence of gallstone disease in Hispanic populations in the United States", Gastroenterology, 96(2 Pt 1), pp.487~492 (1989)
  50. Hanis CL, "An ultrasound survey of gallbladder disease among Mexican Americans in Starr County, Texas: frequencies and risk factors", Ethn Dis, 3, pp.32~43 (1993)
  51. Singh V, "Epidemiology of gallstone disease in Chandigarh: a community-based study", J Gastroenterol Hepatol, 16, pp.560~563 (2001)
  52. Chen CY, "Age is one of the risk factors in developing gallstone disease in Taiwan", Age Ageing, 27, pp.437~441 (1998)
  53. Bagi Abdel M, "Prevalence of gallbladder disease in Sudan: first sonographic field study in adult population", Gastroenterology, 100, pp.A307~ (1991)
  54. Shoda J, "Hepatolithiasis: epidemiology and pathogenesis update", Front Biosci, 8, pp.e398~e409 (2003)
  55. Lammert F, "The genetic background of cholesterol gallstone formation: an inventory of human lithogenic genes", Curr Drug Targets Immune Endocr Metabol Disord, 5, pp.163~170 (2005)
  56. Sarin SK, "High familial prevalence of gallstones in the first-degree relatives of gallstone patients", Hepatology, 22, pp.138~141 (1995)
  57. Gilat T, "An increased familial frequency of gallstones", Gastroenterology, 84, pp.242~246 (1983)
  58. van der Linden W, "The familial occurrence of gallstone disease. II. Occurrence in husbands and wives", Acta Genet Stat Med, 16, pp.377~382 (1966)
  59. Katsika D, "Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs", Hepatology, 41, pp.1138~1143 (2005)
  60. Rudkowska I, "Polymorphisms in ABCG5", G8 transporters linked to hypercholesterolemia and gallstone disease, 2008, pp.66, 343~348
  61. Stinton LM, "Epidemiology of gallstones", Gastroenterol Clin North Am, 39, pp.157~169 (2010)
  62. Mittal B, "Genetics of gallstone disease", J Postgrad Med, 48, pp.149~152 (2002)
  63. Pullinger CR, "Human cholesterol 7alphahydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype", J Clin Invest, 110, pp.109~117 (2002)
  64. Schneider H, "In vitro effects of cholecystokinin fragments on human gallbladders. Evidence for an altered CCK-receptor structure in a subgroup of patients with gallstones", J Hepatol, 26, pp.1063~1068 (1997)
  65. Feng D, "Polymorphism at the LDL receptor gene locus in patients with cholesterol gallstone disease", Zhonghua Yi Xue Za Zhi, 78, pp.63~65 (1998)
  66. Juvonen T, "Polymorphisms at the apoB, apoAI, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease", J Lipid Res, 36, pp.804~812 (1995)
  67. Buch S, "A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease", Nat Genet, 39, pp.995~999 (2007)
  68. Grünhage F, "Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol", Hepatology, 46, pp.793~801 (2007)
  69. Einarsson K, "Influence of age on secretion of cholesterol and synthesis of bile acids by the liver", N Engl J Med, 313, pp.277~282 (1985)
  70. Völzke H, "Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence", Digestion, 71, pp.97~105 (2005)
  71. Cirillo DJ, "Effect of estrogen therapy on gallbladder disease", JAMA, 293, pp.330~339 (2005)
  72. Thijs C, "Oral contraceptives and the risk of gallbladder disease: a meta-analysis", Am J Public Health, 83, pp.1113~1120 (1993)
  73. Hulley S, "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen", progestin Replacement Study (HERS) Research Group, 1998, pp.280, 605~613
  74. Etminan M, "Oral contraceptives and the risk of gallbladder disease: a comparative safety study", CMAJ, 183, pp.899~904 (2011)
  75. Maringhini A, "Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history", Ann Intern Med, 119, pp.116~120 (1993)
  76. Valdivieso V, "Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium", Hepatology, 17, pp.1~4 (1993)
  77. Ko CW, "Insulin resistance and incident gallbladder disease in pregnancy", Clin Gastroenterol Hepatol, 6, pp.76~81 (2008)
  78. Ogden CL, "The epidemiology of obesity", Gastroenterology, 132, pp.2087~2102 (2007)
  79. Ogden CL, "Prevalence of overweight and obesity in the United States, 1999-2004", JAMA, 295, pp.1549~1555 (2006)
  80. Erlinger S, "Gallstones in obesity and weight loss", Eur J Gastroenterol Hepatol, 12, pp.1347~1352 (2000)
  81. Amaral JF, "Gallbladder disease in the morbidly obese", Am J Surg, 149, pp.551~557 (1985)
  82. Johansen C, "Risk of colorectal cancer and other cancers in patients with gall stones", Gut, 39, pp.439~443 (1996)
  83. Tsai CJ, "Prospective study of abdominal adiposity and gallstone disease in US men", Am J Clin Nutr, 80, pp.38~44 (2004)
  84. Li VK, "Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy", Surg Endosc, 23, pp.1640~1644 (2009)
  85. Maclure KM, "Weight, diet, and the risk of symptomatic gallstones in middle-aged women", N Engl J Med, 321, pp.563~569 (1989)
  86. Lambou-Gianoukos S, "Lithogenesis and bile metabolism", Surg Clin North Am, 88, pp.1175~1194 (2008)
  87. Shaffer EA, "Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity", J Clin Invest, 59, pp.828~840 (1977)
  88. Petitti DB, "Association of a history of gallbladder disease with a reduced concentration of high-densitylipoprotein cholesterol", N Engl J Med, 304, pp.1396~1398 (1981)
  89. Ahlberg J, "Serum lipid levels and hyperlipoproteinaemia in gallstone patients", Acta Chir Scand, 145, pp.373~377 (1979)
  90. Barbara L, "A population study on the prevalence of gallstone disease: the Sirmione Study", Hepatology, 7, pp.913~917 (1987)
  91. Thijs C, "Serum lipids and gallstones: a case-control study", Gastroenterology, 99, pp.843~849 (1990)
  92. Sakuta H, "Plasma total homocysteine and gallstone in middle-aged Japanese men", J Gastroenterol, 40, pp.1061~1064 (2005)
  93. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
  94. Eckel RH, "The metabolic syndrome", Lancet, 365, pp.1415~1428 (2005)
  95. Méndez-Sánchez N, "Metabolic syndrome as a risk factor for gallstone disease", World J Gastroenterol, 11, pp.1653~1657 (2005)
  96. Ata N, "The metabolic syndrome is associated with complicated gallstone disease", Can J Gastroenterol, 25, pp.274~276 (2011)
  97. Ruhl CE, "Association of diabetes, serum insulin, and C-peptide with gallbladder disease", Hepatology, 31, pp.299~303 (2000)
  98. Nervi F, "Gallbladder disease is associated with insulin resistance in a high risk Hispanic population", J Hepatol, 45, pp.299~305 (2006)
  99. Biddinger SB, "Hepatic insulin resistance directly promotes formation of cholesterol gallstones", Nat Med, 14, pp.778~782 (2008)
  100. Twisk J, "Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription", Hepatology, 21, pp.501~510 (1995)
  101. Nakeeb A, "Insulin resistance causes human gallbladder dysmotility", J Gastrointest Surg, 10, pp.940~948 (2006)
  102. Everhart JE, "Contributions of obesity and weight loss to gallstone disease", Ann Intern Med, 119, pp.1029~1035 (1993)
  103. Yang H, "Risk factors for gallstone formation during rapid loss of weight", Dig Dis Sci, 37, pp.912~918 (1992)
  104. Weinsier RL, "Gallstone formation and weight loss", Obes Res, 1, pp.51~56 (1993)
  105. Liddle RA, "Gallstone formation during weight-reduction dieting", Arch Intern Med, 149, pp.1750~1753 (1989)
  106. Shiffman ML, "Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity", Am J Gastroenterol, 86, pp.1000~1005 (1991)
  107. Broomfield PH, "Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight", N Engl J Med, 319, pp.1567~1572 (1988)
  108. Wudel LJ Jr, "Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study", J Surg Res, 102, pp.50~56 (2002)
  109. Weinsier RL, "Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation", Am J Med, 98, pp.115~117 (1995)
  110. Al-Jiffry BO, "Changes in gallbladder motility and gallstone formation following laparoscopic gastric banding for morbid obestity", Can J Gastroenterol, 17, pp.169~174 (2003)
  111. Syngal S, "Long-term weight patterns and risk for cholecystectomy in women", Ann Intern Med, 130, pp.471~477 (1999)
  112. Jørgensen T, "Gallstones and diet in a Danish population", Scand J Gastroenterol, 24, pp.821~826 (1989)
  113. Méndez-Sánchez N, "Role of diet in cholesterol gallstone formation", Clin Chim Acta, 376, pp.1~8 (2007)
  114. Cuevas A, "Diet as a risk factor for cholesterol gallstone disease", J Am Coll Nutr, 23, pp.187~196 (2004)
  115. Tseng M, "Dietary intake and gallbladder disease: a review", Public Health Nutr, 2, pp.161~172 (1999)
  116. Lee DW, "Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects", Am J Clin Nutr, 42, pp.414~420 (1985)
  117. Tsai CJ, "Long-chain saturated fatty acids consumption and risk of gallstone disease among men", Ann Surg, 247, pp.95~103 (2008)
  118. Scragg RK, "Diet, alcohol, and relative weight in gall stone disease: a case-control study", Br Med J (Clin Res Ed), 288, pp.1113~1119 (1984)
  119. Tsai CJ, "Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men", Gut, 54, pp.823~828 (2005)
  120. Nervi F, "Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Identification of a dietary risk factor for cholesterol gallstone formation in a highly prevalent area", Gastroenterology, 96, pp.825~830 (1989)
  121. Tsai CJ, "The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study", Ann Intern Med, 141, pp.514~522 (2004)
  122. Leitzmann MF, "A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men", JAMA, 281, pp.2106~2112 (1999)
  123. Leitzmann MF, "Coffee intake is associated with lower risk of symptomatic gallstone disease in women", Gastroenterology, 123, pp.1823~1830 (2002)
  124. Leitzmann MF, "Alcohol consumption in relation to risk of cholecystectomy in women", Am J Clin Nutr, 78, pp.339~347 (2003)
  125. Attili AF, "Diet and gallstones in Italy: the cross-sectional MICOL results", Hepatology, 27, pp.1492~1498 (1998)
  126. Simon JA, "Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III)", Arch Intern Med, 160, pp.931~936 (2000)
  127. Simon JA, "Serum ascorbic acid and other correlates of gallbladder disease among US adults", Am J Public Health, 88, pp.1208~1212 (1998)
  128. Leitzmann MF, "Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men", Alcohol Clin Exp Res, 23, pp.835~841 (1999)
  129. Su CH, "Relative prevalence of gallstone diseases in Taiwan. A nationwide cooperative study", Dig Dis Sci, 37, pp.764~768 (1992)
  130. Kameda H, "Clinical and nutritional study on gallstone disease in Japan", Jpn J Med, 23, pp.109~113 (1984)
  131. Guglielmi FW, "Total parenteral nutrition-related gastroenterological complications", Dig Liver Dis, 38, pp.623~642 (2006)
  132. Roslyn JJ, "Gallbladder disease in patients on long-term parenteral nutrition", Gastroenterology, 84, pp.148~154 (1983)
  133. Baudet S, "Effect of short-term octreotide therapy and total parenteral nutrition on the development of biliary sludge and lithiasis", Hepatogastroenterology, 49, pp.609~612 (2002)
  134. Angelico M, "Review article: hepatobiliary complications associated with total parenteral nutrition", Aliment Pharmacol Ther, 14(Suppl 2), pp.54~57 (2000)
  135. Messing B, "Does total parenteral nutrition induce gallbladder sludge formation and lithiasis?", Gastroenterology, 84(5 Pt 1), pp.1012~1019 (1983)
  136. Shaffer EA, "Gallbladder sludge: what is its clinical significance?", Curr Gastroenterol Rep, 3, pp.166~173 (2001)
  137. Diehl AK, "Socioeconomic status and the prevalence of clinical gallbladder disease", J Chronic Dis, 38, pp.1019~1026 (1985)
  138. Sahi T, "Body mass index, cigarette smoking, and other characteristics as predictors of selfreported, physician-diagnosed gallbladder disease in male college alumni", Am J Epidemiol, 147, pp.644~651 (1998)
  139. Leitzmann MF, "Recreational physical activity and the risk of cholecystectomy in women", N Engl J Med, 341, pp.777~784 (1999)
  140. Banim PJ, "Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study", Eur J Gastroenterol Hepatol, 22, pp.983~988 (2010)
  141. Acalovschi M, "Prevalence of gallstones in liver cirrhosis: a sonographic survey", Am J Gastroenterol, 83, pp.954~956 (1988)
  142. Conte D, "Cholelithiasis in cirrhosis: analysis of 500 cases", Am J Gastroenterol, 86, pp.1629~1632 (1991)
  143. Conte D, "Close relation between cirrhosis and gallstones: cross-sectional and longitudinal survey", Arch Intern Med, 159, pp.49~52 (1999)
  144. Alvaro D, "Physico-chemical factors predisposing to pigment gallstone formation in liver cirrhosis", J Hepatol, 10, pp.228~234 (1990)
  145. Loria P, "Gallstone disease in nonalcoholic fatty liver: prevalence and associated factors", J Gastroenterol Hepatol, 20, pp.1176~1184 (2005)
  146. Méndez-Sánchez N, "Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects", World J Gastroenterol, 11, pp.6182~6187 (2005)
  147. Chen CH, "Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey", J Gastroenterol Hepatol, 21, pp.1737~1743 (2006)
  148. Acalovschi M, "Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis", J Viral Hepat, 16, pp.860~866 (2009)
  149. Whorwell PJ, "Ultrasound survey of gallstones and other hepatobiliary disorders in patients with Crohn’s disease", Dig Dis Sci, 29, pp.930~933 (1984)
  150. Hutchinson R, "Pathogenesis of gall stones in Crohn’s disease: an alternative explanation", Gut, 35, pp.94~97 (1994)
  151. Brink MA, "Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn’s disease", Gastroenterology, 116, pp.1420~1427 (1999)
  152. Lapidus A, "Gallbladder bile composition in patients with Crohn’s disease", World J Gastroenterol, 12, pp.70~74 (2006)
  153. Vítek L, "Enterohepatic cycling of bilirubin as a cause of ‘black’ pigment gallstones in adult life", Eur J Clin Invest, 33, pp.799~810 (2003)
  154. Apstein MD, "Spinal cord injury is a risk factor for gallstone disease", Gastroenterology, 92, pp.966~968 (1987)
  155. Rotter KP, "Gallstones in spinal cord injury (SCI): a late medical complication?", Spinal Cord, 41, pp.105~108 (2003)
  156. Xia CS, "Spinal cord injury and cholelithiasis", Hepatobiliary Pancreat Dis Int, 3, pp.595~598 (2004)
  157. Kennedy TM, "Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population", Br J Surg, 87, pp.1658~1663 (2000)
  158. Ros E, "Postcholecystectomy symptoms. A prospective study of gall stone patients before and two years after surgery", Gut, 28, pp.1500~1504 (1987)
  159. Creutzfeldt W, "Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans", Am J Med, 82(5B), pp.49~54 (1987)
  160. Trendle MC, "Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors", Cancer, 79, pp.830~834 (1997)
  161. Roti E, "Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurrence of cholelithiasis", J Endocrinol Invest, 13, pp.69~72 (1990)
  162. Lopez AJ, "Ceftriaxoneinduced cholelithiasis", Ann Intern Med, 115, pp.712~714 (1991)
  163. Bickford CL, "Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature", Pharmacotherapy, 25, pp.1389~1395 (2005)
  164. Angelin B, "Effect of thiazide treatment on biliary lipid composi-tion in healthy volunteers", Eur J Clin Pharmacol, 37, pp.95~96 (1989)
  165. Rosenberg L, "Thiazides and acute cholecystitis", N Engl J Med, 303, pp.546~548 (1980)
  166. Van der Linden W, "Acute cholecystitis and thiazides", Br Med J (Clin Res Ed), 289, pp.654~655 (1984)
  167. Leitzmann MF, "Thiazide diuretics and the risk of gallbladder disease requiring surgery in women", Arch Intern Med, 165, pp.567~573 (2005)
  168. Tsai CJ, "Statin use and the risk of cholecystectomy in women", Gastroenterology, 136, pp.1593~1600 (2009)
  169. St Peter SD, "Laparoscopic cholecystectomy in the pediatric population", J Laparoendosc Adv Surg Tech A, 18, pp.127~130 (2008)
  170. Palasciano G, "Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index", Am J Gastroenterol, 84, pp.1378~1382 (1989)
  171. Kaechele V, "Prevalence of gallbladder stone disease in obese children and adolescents: influence of the degree of obesity, sex, and pubertal development", J Pediatr Gastroenterol Nutr, 42, pp.66~70 (2006)
  172. Kratzer W, "Gallstone prevalence and risk factors for gallstone disease in an urban population of children and adolescents", Z Gastroenterol, 48, pp.683~687 (2010)
  173. Bogue CO, "Risk factors, complications, and outcomes of gallstones in children: a single-center review", J Pediatr Gastroenterol Nutr, 50, pp.303~308 (2010)
  174. Holcomb GW Jr, "Cholelithiasis in infants, children, and adolescents", Pediatr Rev, 11, pp.268~274 (1990)
  175. Friesen CA, "Cholelithiasis. Clinical characteristics in children. Case analysis and literature review", Clin Pediatr, 28, pp.294~298 (1989)
  176. Waldhausen JH, "Cholecystectomy is becoming an increasingly common operation in children", Am J Surg, 177, pp.364~367 (1999)
  177. Wesdorp I, "Clinical presentations and predisposing factors of cholelithiasis and sludge in children", J Pediatr Gastroenterol Nutr, 31, pp.411~417 (2000)
  178. Kumar R, "Gallstones and common bile duct calculi in infancy and childhood", Aust N Z J Surg, 70, pp.188~191 (2000)
  179. Henson DE, "Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates", Cancer, 70, pp.1493~1497 (1992)
  180. Wistuba II, "Gallbladder cancer: lessons from a rare tumour", Nat Rev Cancer, 4, pp.695~706 (2004)
  181. Lai CH, "Gallbladder cancer: a comprehensive review", Surgeon, 6, pp.101~110 (2008)
  182. Levy AD, "Gallbladder carcinoma: radiologic-pathologic correlation", Radiographics, 21, pp.295~314 (2001)
  183. Pandey M, "Risk factors for gallbladder cancer: a reappraisal", Eur J Cancer Prev, 12, pp.15~24 (2003)
  184. Lazcano-Ponce EC, "Epidemiology and molecular pathology of gallbladder cancer", CA Cancer J Clin, 51, pp.349~364 (2001)
  185. Randi G, "Gallbladder cancer worldwide: geographical distribution and risk factors", Int J Cancer, 118, pp.1591~1602 (2006)
  186. Andia ME, "Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study", Int J Cancer, 123, pp.1411~1416 (2008)
  187. Serra I, "Gastric and gallbladder carcinoma in Chile: epidemiological changes and control programs", Rev Med Chil, 117, pp.834~836 (1989)
  188. Hsing AW, "Family history of gallstones and the risk of biliary tract cancer and gallstones: a populationbased study in Shanghai, China", Int J Cancer, 121, pp.832~838 (2007)
  189. Hariharan D, "Analysis of mortality rates for gallbladder cancer across the world", HPB, 10, pp.327~331 (2008)
  190. Shrikhande SV, "Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause!", Eur J Surg Oncol, 36, pp.514~519 (2010)
  191. Diehl AK, "Gallstone size and the risk of gallbladder cancer", JAMA, 250, pp.2323~2326 (1983)
  192. Csendes A, "Number and size of stones in patients with asymptomatic and symptomatic gallstones and gallbladder carcinoma: a prospective study of 592 cases", J Gastrointest Surg, 4, pp.481~485 (2000)
  193. Zatonski WA, "Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer", J Natl Cancer Inst, 89, pp.1132~1138 (1997)
  194. Kimura W, "Carcinoma of the gallbladder and extrahepatic bile duct in autopsy cases of the aged, with special reference to its relationship to gallstones", Am J Gastroenterol, 84, pp.386~390 (1989)
  195. Diehl AK, "Cholecystectomy and changing mortality from gallbladder cancer", Lancet, 2, pp.187~189 (1981)
  196. Tewari M, "Contribution of silent gallstones in gallbladder cancer", J Surg Oncol, 93, pp.629~632 (2006)
  197. Randi G, "Gallbladder cancer worldwide: geographical distribution and risk factors", Int J Cancer, 118, pp.1591~1602 (2006)
  198. Sheth S, "Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy", Am J Gastroenterol, 95, pp.1402~1410 (2000)
  199. Stephen AE, "Carcinoma in the porcelain gallbladder: a relationship revisited", Surgery, 129, pp.699~703 (2001)
  200. Berk RN, "Carcinoma in the porcelain gallbladder", Radiology, 106, pp.29~31 (1973)
  201. Cunningham SC, "Porcelain gallbladder and cancer: ethnicity explains a discrepant literature?", Am J Med, 120, pp.e17~e18 (2007)
  202. Kim JH, "Should we perform surgical management in all patients with suspected porcelain gallbladder?", Hepatogastroenterology, 56, pp.943~945 (2009)
  203. Kumar S, "Infection as a risk factor for gallbladder cancer", J Surg Oncol, 93, pp.633~639 (2006)
  204. Dutta U, "Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder", Am J Gastroenterol, 95, pp.784~787 (2000)
  205. Tewari M, "Salmonella typhi and gallbladder cancer: report from an endemic region", Hepatobiliary Pancreat Dis Int, 9, pp.524~530 (2010)
  206. Matsukura N, "Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract", Jpn J Cancer Res, 93, pp.842~847 (2002)
  207. Lewis JT, "Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasiadysplasia-carcinoma sequence", Am J Surg Pathol, 31, pp.907~913 (2007)
  208. Nomura T, "Cholangiographic criteria for anomalous union of the pancreatic and biliary ducts", Gastrointest Endosc, 55, pp.204~208 (2002)
  209. Babbitt DP, "Choledochal cyst: a concept of etiology", Am J Roentgenol Radium Ther Nucl Med, 119, pp.57~62 (1973)
  210. Kang CM, "Gallbladder carcinoma associated with anomalous pancreaticobiliary duct junction", Can J Gastroenterol, 21, pp.383~387 (2007)
  211. Goldgar DE, "Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands", J Natl Cancer Inst, 86, pp.1600~1608 (1994)
  212. Hemminki K, "Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden", Gut, 52, pp.592~596 (2003)
  213. Venniyoor A, "Cholesterol gallstones and cancer of gallbladder (CAGB): molecular links", Med Hypotheses, 70, pp.646~653 (2008)
  214. Myers RP, "Gallbladder polyps: epidemiology, natural history and management", Can J Gastroenterol, 16, pp.187~194 (2002)
  215. Calle EE, "The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics", Cancer, 94, pp.2490~2501 (2002)
  216. Larsson SC, "Obesity and the risk of gallbladder cancer: a meta-analysis", Br J Cancer, 96, pp.1457~1461 (2007)
  217. Yagyu K, "Cigarette smoking, alcohol drinking and the risk of gallbladder cancer death: a prospective cohort study in Japan", Int J Cancer, 122, pp.924~929 (2008)
  218. Chow WH, "Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas", Br J Cancer, 79, pp.640~644 (1999)
  219. Ishiguro S, "Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification", Cancer Causes Control, 19, pp.33~41 (2008)
  220. Zatonski WA, "Risk factors for gallbladder cancer: a Polish case-control study", Int J Cancer, 51, pp.707~711 (1992)
  221. Khan ZR, "Risk factors for biliary tract cancers", Am J Gastroenterol, 94, pp.149~152 (1999)
  222. Hsing AW, "Gallstones and the risk of biliary tract cancer: a population-based study in China", Br J Cancer, 97, pp.1577~1582 (2007)
  223. Lowenfels AB, "Gallstone growth, size, and risk of gallbladder cancer: an interracial study", Int J Epidemiol, 18, pp.50~54 (1989)
  224. Caygill CP, "Cancer mortality in chronic typhoid and paratyphoid carriers", Lancet, 343, pp.83~84 (1994)
  225. Strom BL, "Risk factors for gallbladder cancer. An international collaborative case-control study", Cancer, 76, pp.1747~1756 (1995)
  226. Murata H, "Helicobacter bilis infection in biliary tract cancer", Aliment Pharmacol Ther, 20(Suppl 1), pp.90~94 (2004)

관련 논문AI추천

Prevalence and Risk Factors of Gallbladder Polypoid Lesions in a Healthy Population강현, 도재혁, 민윤주, 서석원, 오형철, 이승은, 최유신연세대학교의과대학 · Yonsei Medical Journal2016 · 제57권 제6호Visceral Obesity Is Associated with Gallbladder Polyps정재규, Han Seok Choi, Hyoun Woo Kang, In Woong Han, Jae Hyun Kwon, Jin-Hee Jung, Jin Ho Lee, Jun Kyu Lee, Suk Jae Hahn거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제1호Differences in the Impact of Obesity and Metabolic Unhealthiness on the Risk of Gallbladder Polyp강지훈, 김남희, 김홍주연세대학교의과대학 · Yonsei Medical Journal2023 · 제64권 제11호Prevalence of cholesterol gallstones in a Korean population over a 14-year periodGyumin Lee, Hyoung-Chul Oh, Hyun Kang, Jae Hyuk Do, Jeong Yoon Suh, Junyeol Kim, Seung Eun Lee, Tae Yoon Lee, Tae Young Park, Yoo Shin Choi대한내과학회 · The Korean Journal of Internal Medicine2025 · 제40권 제4호Association between gallstones and the risk of biliary tract cancer risk: a systematic review and meta-analysis신애선, Cho Sooyoung, HUANGDAN, Joo Hyundeok, Kim Woosung, Song Nan한국역학회 · Epidemiology and Health2021 · 제43권 Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family PhysiciansAgostino Di Ciaula, Ignazio Grattagliano, Piero Portincasa대한가정의학회 · Korean Journal of Family Medicine2016 · 제37권 제4호

이 간행물의 다른 논문 (18건)

The Optimal Selection of Radiotherapy Treatment for Hepatocellular Carcinoma성진실, 이익재pp. 139-148NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic ImplicationsGeoffrey C. Farrell, Lay Gan, Derrick van Rooyen, Shivrakumar Chitturipp. 149-171Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived Macrophages이완식, Kang-Jin Park, So-Young Joo, Young-A Song, Young-Lan Park, Eun Myung, Cho-Yun Chung, 김현수, 유종선, 주영은, 조성범, 김낙성pp. 188-196Reflux Episode Reaching the Proximal Esophagus Are Associated with Chronic Cough박창환, 고영일, 이완식, Jeong-Hyun Lee, 조성범, 최성규, 주영은, 유종선, 박선영, 김현수pp. 197-202Prognostic Signifi cance of the Lymph Node Ratio Regarding Recurrence and Survival in Rectal Cancer Patients Treated with Postoperative ChemoradiotherapyIn-Kyu Lee, 안창혁, 유미령, 원종만, Ji-Yoon Kim, 정수미, 최병옥pp. 203-209
원문 보기